| Name | Title | Contact Details |
|---|
VetEvolve offers relationship-focused veterinary practice acquisition that helps you put the focus back on your patients with our superior business management.
The Office of the National Coordinator for Health Information Technology (ONC) is the lead agency charged with formulating the federal government’s health IT strategy and coordinating federal health IT policies, standards, programs, and investments. ONC is organizationally located within the Office of the Secretary for the U.S. Department of Health and Human Services (HHS). The position of National Coordinator was created in 2004, through an Executive Order, and legislatively mandated in the Health Information Technology for Economic and Clinical Health Act (HITECH Act) of 2009.
Audiometrics is a Oceanside, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
The AMERICAN ACADEMY OF PEDIATRICS, AZ Chapter is a Phoenix, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Versartis, Inc. (NASDAQ: VSAR) is an endocrine-focused biopharmaceutical company developing novel, long-acting medicines to transform treatment for patients with endocrine disorders. The company is led by a management team with rich experience and expertise discovering, developing and commercializing innovative therapeutics for the life sciences industry. Versartis` mission is to develop, manufacture and commercialize novel therapeutics to improve and transform treatment for patients with orphan endocrine disorders. Versartis is well-positioned to deliver a major innovation to the global growth hormone deficiency (GHD) market with the company`s most advanced clinical candidate, somavaratan. Somavaratan is a novel, long-acting form of recombinant human growth hormone that is in global late-stage clinical trials to treat GHD in children and adults. Twice-monthly somavaratan is intended to reduce the burden of daily injection therapy by requiring significantly fewer injections, potentially improving compliance/adherence and treatment outcomes.